Compare CMRE & ENOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CMRE | ENOV |
|---|---|---|
| Founded | 1974 | 1995 |
| Country | Monaco | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Fluid Controls |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.5B |
| IPO Year | 2010 | 2008 |
| Metric | CMRE | ENOV |
|---|---|---|
| Price | $15.27 | $19.41 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 9 |
| Target Price | $12.00 | ★ $47.38 |
| AVG Volume (30 Days) | 341.2K | ★ 1.4M |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.10% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $6.36 |
| Revenue Next Year | N/A | $5.31 |
| P/E Ratio | $5.55 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.84 | $18.08 |
| 52 Week High | $18.06 | $34.28 |
| Indicator | CMRE | ENOV |
|---|---|---|
| Relative Strength Index (RSI) | 45.41 | 30.35 |
| Support Level | $13.86 | N/A |
| Resistance Level | $15.86 | $27.20 |
| Average True Range (ATR) | 0.46 | 1.27 |
| MACD | -0.04 | -0.62 |
| Stochastic Oscillator | 15.25 | 3.33 |
Costamare Inc is an international owner and operator of containerships and dry bulk vessels. The company charter its containerships to the liner companies, providing transportation of containerized cargoes. It charter its dry bulk vessels to a wide variety of customers, providing transportation for dry bulk cargoes. The company's fleet of vessels includes Cosco Guangzhou, Cosco Ningbo, Cosco Yantian, Vantage, Valor, Valiant, Maersk Kobe, and others. The company provides services to ocean carriers that demand a high standard of safety and reliability. It generates a majority of its revenue from the United States of America.
Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recovery segment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries.